175
While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short when it comes to making data publicly accessible, according to new Flinders University research.
Improved accessibility
Researchers evaluated the Individual Participant Data (IPD)-sharing for each trial that supported Food and Drug Administration (FDA) approval for the 30 highest-revenue medicines for 2021.
The audit found that of the 316 clinical trials conducted for the top-selling medicines, 201 trials (64%) had data accessible to researchers. However, 102…